NOVAGO 10CPR 50MG

NOVAGO 50 MG COMPRESENT

active ingredients

One tablet contains: Active ingredient: dimenhydrate 50 mg. For the full list of excipients, see paragraph 6.1.

Excellent

Corn starch, Lactose monohydrate, Talco, Magnesium stearate.

Therapeutic indications

Antivomite, antinausea, antivirgine in the cinetosis.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients or other antihistamines. Pregnancy and nursing. New preterms and completions.

Population

Adults and teenagers (from 13 years to 18 years of age): 1 tablet half an hour before the trip; if necessary repeat the dose after 3-4 hours, up to a maximum of 4 tablets in 24 hours. Children (from 6 years to 12 years of age): Half an hour before the trip; if necessary repeat the dose of half tablet after 6-8 hours, up to a maximum of 2 tablets (4 half tablets) in 24 hours. The tablets have a fracture line that makes their subdivision easy in two halves.

Conservation

There are no special conditions for conservation.

Warnings

Use with caution in subjects suffering from glaucoma, prostatic hypertrophy, other urinary retention syndromes, intestinal obstruction, bronchial asthma, epilepsy. Novago contains lactose: use with caution in patients suffering from rare hereditary problems of galactose intolerance, lactase deficiency, or glucose/galactosis mal absorption.

Interactions

Dimenhydrate enhances the effects of: - depressive agents of the Central Nervous System, such as alcohol, barbiturates, other hypnotics, sedatives or tranquilizers. In the event of concomitant intake of such substances, attention must be paid to the purpose of avoiding additional phenomena of sedation; - anticholinergic drugs, including antidepressants. If administered in conjunction with aminoglycosidic antibiotics or other ototoxic drugs, dimenhydrate may mask the first symptoms of ototoxicity, which can only be detected when the damage is irreversible.

Effects

Below are the undesirable effects of dimenhydrate, organized according to the organic systemic classification MedDRA. The estimated frequency of events is based on the following convention: very common (>1/10); common (≥ 1/100, Classification Organic Systems Very common Municipalities Not common Immune system disorders   Skin reactions   Disorders of metabolism and nutrition   Anorexia   Psychiatric disorders     Insomnia (especially in children) Euforia Diseases of the nervous system Sedazione Sonnolenza Cefa Vertigo Tremori Pathologies of the eye   Disorders of acceptance   Heart disease     Tachycardia Vascular diseases     Hypotension Gastrointestinal diseases   Dryness of the mouths Nausea   Pathologies of skin and subcutaneous tissue   Photosensitivity   Kidney and urinary pathologies   Disorders of urination   Systemic pathologies and conditions for administration     Austria Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

Synonyms Sedation that may vary from a slight intonement to a deep sleep. Psychic symptoms are reported. In children can occur, following overdose, states of excitement, insomnia, nervousness, tachycardia, tremors, myclonies, seizures. Treatment If the drug has recently been taken to practice gastric washing. In case of severe hypotension administer rightno 70 for intravenous infusion. It may be necessary to provide symptomatic therapy.

Do not administer the medicine during pregnancy. It is not recommended to use it in infants and premature, as well as during breastfeeding.

Source: Farmadati